Overview - Managing Nicotine Withdrawal in Medically Ill Patients

Activity Details
  • Credit Type: Other
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Jun 16, 2016
  • Expires: Jan 1, 2018
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Audrey Darville Audrey Darville, PhD, APRN, CTTS
Certified Tobacco Treatment Specialist
UK Healthcare
Assistant Professor
University of Kentucky College of Nursing
Lexington, Kentucky

Angela Tackett Dearinger Angela Tackett Dearinger, MD, MPH, FACP, FAAP
Associate Professor, Internal Medicine
Assistant Dean, Accreditation, GME
University of Kentucky College of Medicine
Associate Professor, Health Services Management
University of Kentucky College of Public Health
Lexington, Kentucky

Needs Statement

Globally, tobacco use is the leading cause of preventable death. Despite this, a recent evaluation of the National Health Interview Survey (Kruger, Shaw, Kahende & Frank, 2012) found that healthcare providers are becoming less likely to advise their patients to quit smoking, although nearly 68% of smokers want to quit. In Kentucky tobacco use prevalence rates among adults are the highest in the nation.

Nicotine replacement is underutilized in medically ill patients. Yet there is strong evidence to support its use in improving symptoms of nicotine withdrawal and promoting tobacco use cessation.

Target Audience

Health care providers who manage patients with tobacco dependence in medical and surgical specialty settings.

Objectives

At the end of the session, the participant will be able to:

1. Recognize the impact of nicotine withdrawal on patient comfort and outcomes
2. Describe five symptoms of nicotine withdrawal
3. Identify nicotine withdrawal treatment options including dosing strategies and potential side effects
4. Review current Clinical Practice Guidelines and evidence-based recommendations for treating tobacco dependence

Accreditation

Other
UK Healthcare CECentral certifies this activity for 1.00 hour of participation.

Faculty Disclosure

Audrey Darville, PhD, APRN, CTTS (speaker) has received partial salary support from an unrestricted Pfizer Medical Education Grant in collaboration with the Smoking Cessation Leadership Center for the purpose of developing and producing these modules. She has no other relevant financial relationships with commercial interests. 

Angela Dearinger, MD, MPH, FAAP (speaker) has received partial salary support from an unrestricted Pfizer Medical Education Grant in collaboration with the Smoking Cessation Leadership Center for the purpose of developing and producing these modules. She has no other relevant financial relationships with commercial interests. 

Dr. Darville & Dr. Dearinger will discuss off label use of a product.

No other authors, planners or content reviewers have any relevant financial relationships to disclose. 

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation